SCHEMBL4954992

SCHEMBL4954992

CC=CNc1cccc2c1C(=O)N=NC2=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.34
MAPT P10636 1/20 0.34
PABPC1 P11940 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAOA P21397 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
CASP1 P29466 1/20 0.30
BRCA1 P38398 1/20 0.30
CASP7 P55210 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4958638 0.83 PABPC1 (0.41) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4955038 0.81 EGFR (0.32) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4958613 0.79 MAPT (0.55) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4954958 0.75 MAPT (0.34) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4956778 0.75 EGFR (0.34) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4953834 0.75 EGFR (0.34) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4958351 0.75 MAPT (0.34) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4954966 0.75 EGFR (0.34) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4958290 0.75 EGFR (0.34) EGFRMAPTPABPC1MAPK1RAB9A
SCHEMBL4958192 0.75 DDB1 (0.40) EGFRMAPTPABPC1MAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9968602-B2 Modulation of cell fates and activities by phthalazinediones BACH PHARMA, INC. (US) 2018-05-15 US claimed
US-20140030317-A1 MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES Occhiuti & Rohlicek LLP 2014-01-30 US claimed
US-7326690-B2 Modulation of cell fates and activities by phthalazinediones BACH PHARMA, INC. (US) 2008-02-05 US claimed
US-20070142303-A1 Modulation of cell fates and activities by phthalazinediones BACH PHARMA, INC. (US) 2007-06-21 US claimed